Advances in neuroscience and neurotechnology come with promises of new treatments but they also present important societal and ethical concerns including those of dual-use, misuse, and unintended use. Over the past eight years, the Responsible Research and Innovation (RRI) team of the Human Brain Project (HBP) has undertaken research, engagement, and co-creation activities in collaboration with many stakeholders within and beyond the HBP to develop a novel approach to address these issues.
This approach considers a broad range of potential concerns of using neuroscience and neurotechnology in political, security, intelligence, military, and other areas. To identify and address potential concerns, our approach uses the RRI concept and its AREA (anticipation, reflection, engagement, and action) framework focusing on societal needs. This approach has been outlined in our ‘Opinion on Responsible Dual-Use. Political, Security, Intelligence and Military research of concern in Neuroscience and Neurotechnology.’ The follow-up actions are developed and implemented by a project-wide Dual-Use Working Group in collaboration with the Ethics Rapporteur Programme.
This webinar will provide an introduction to the HBP approach to addressing dual-use research of concern and its implementation. It will also discuss challenges encountered in this work.
When: 16 June 13-14 CEST
- Dr. Inga Ulnicane (De Montfort University, UK), chair of the HBP Dual-Use Working Group
- Dr. Manuel Guerrero (Uppsala University, Sweden), co-chair of the HBP Dual-Use Working Group and chair of the HBP Ethics Rapporteur Programme
Want to read the opinion?
Aicardi, Christine; Bitsch, Lise; Bang Bådum, Nicklas; Datta, Saheli; Evers, Kathinka; Farisco, Michele; Fothergill, Tyr; Giordano, James; Harris, Emma; Jørgensen, Marie Louise; Klüver, Lars; Mahfoud, Tara; Rainey, Stephen; Riisgaard, Karen; Rose, Nikolas; Salles, Arleen; Stahl, Bernd; Ulnicane, Inga (2021, March 8). Opinion on ‘Responsible Dual Use’ Political, Security, Intelligence and Military Research of Concern in Neuroscience and Neurotechnology. Zenodo.